Key FDA MQSA Regulatory Documents: A Practitioner's Reference

Background: Why the Regulatory History Matters

The Mammography Quality Standards Act was enacted by Congress in 1992 in direct response to a fragmented regulatory landscape — a patchwork of federal, state, and private standards that produced uneven quality across mammography facilities nationwide. The legislation established a single national framework requiring every facility performing mammography (with the exception of Department of Veterans Affairs facilities) to be accredited by an FDA-approved accreditation body and certified by the Secretary of Health and Human Services before legally providing services after October 1, 1994.

FDA implemented interim final rules in December 1993 and September 1994 to stand up the certification framework quickly. In April 1996, the agency proposed comprehensive replacements — reflecting its view that more rigorous quality standards would better optimize facility performance. The comprehensive final rule was published in October 1997, with most provisions taking effect April 28, 1999.

What followed over the next two-and-a-half decades was a series of targeted amendments, corrections, and guidance documents — each building on what came before rather than starting over. The FDA's approach has consistently been to amend specific sections of the existing regulation, leaving foundational requirements intact and in force. This means that a compliance officer, policy writer, or accreditation auditor cannot rely on any single Federal Register document to understand the full scope of current requirements. The operative regulation at any given moment is the cumulative product of every ruling that has preceded it.

The 2023 comprehensive update — the most significant revision in more than 25 years — illustrates this clearly. The final rule modernized personnel qualification standards, updated quality control requirements for digital and tomosynthesis technology, strengthened audit and corrective action provisions, and introduced new patient notification requirements. But it did so by amending 21 CFR Part 900, not replacing it. Provisions from the 1997/1999 framework that were not explicitly superseded remain in effect. To understand why a current policy requirement exists and what it actually requires, you often need to trace the language back through multiple rulings spanning decades.

The four Federal Register documents listed below represent the key publications that have shaped the MQSA compliance framework applicable to standard breast imaging practice. They are the primary sources any facility should have at hand when developing, reviewing, or defending its policies and procedures.

Using the Federal Register Effectively

The Federal Register (federalregister.gov) is the official daily journal of the U.S. federal government. Every proposed rule, final rule, and regulatory notice from FDA appears here first. Several built-in tools make it an effective ongoing compliance resource:

Full-Text Search — Search by CFR citation, agency, docket number, or keyword. Use advanced filters to narrow by date range and document type (final rule vs. proposed rule vs. notice).

Browse by Agency — Navigate directly to all FDA publications. Useful for monitoring new MQSA-related notices without knowing exact docket numbers in advance.

My Clipboard — Save specific documents for quick access. Compliance officers can maintain a working set of the documents most relevant to their facility's active policy review cycle.

My Subscriptions — Subscribe to email alerts for specific agencies, docket numbers, or search terms. Receive notification the moment FDA publishes anything touching MQSA — critical for staying ahead of regulatory changes.

The Four Core MQSA Federal Register Documents

1. Quality Mammography Standards; Correcting Amendment — 63 FR 56555

Published: October 22, 1998 | Effective: April 28, 1999 | Docket: 95N-0192 | Pages: 5

Addressed technical conflicts discovered between the October 1997 final rule requirements and the FDA's existing Electronic Product Radiation Control (EPRC) performance standards. Certain mammographic x-ray systems could not simultaneously satisfy both sets of requirements due to design features manufacturers had incorporated to comply with EPRC. This correcting amendment resolved those conflicts before the April 28, 1999 effective date, ensuring facilities could achieve compliance without equipment redesign.

View on Federal Register →

---

2. Quality Mammography Standards — 64 FR 18331

Published: April 14, 1999 | Effective: April 28, 1999 | Docket: 98N-0728 | Pages: 3

A final rule making targeted amendments to the comprehensive Quality Mammography Standards regulation that had been published in October 1997. This document addressed specific technical requirements — primarily equipment and equipment quality assurance provisions — and finalized adjustments that had been proposed following public comment. Several provisions were delayed until October 28, 2002 to allow manufacturers time to bring equipment into compliance. This ruling solidified the foundational personnel, equipment, and quality control framework that remains the structural backbone of MQSA compliance today.

View on Federal Register →

---

3. Mammography Quality Standards Act — 88 FR 15126

Published: March 10, 2023 | Effective: September 10, 2024 | Docket: FDA-2013-N-0134 | Pages: 46

The most comprehensive revision to MQSA regulations in more than 25 years — the culmination of a rulemaking process that began with a 2013 docket. This 46-page final rule modernized personnel qualification standards, updated quality control requirements to reflect advances in digital and tomosynthesis technology, strengthened audit and corrective action requirements, and added new provisions around patient notification and lay summary communications. Facilities had until September 10, 2024 to achieve full compliance. Critically, this rule amended — not replaced — prior provisions, meaning the 1997/1999 framework remains in force except where explicitly superseded.

View on Federal Register →

---

4. Small Entity Compliance Guide — 89 FR 68364

Published: August 26, 2024 | Effective: N/A (Guidance Document) | Docket: FDA-2013-N-0134 | Pages: 2

A Federal Register notice announcing the availability of FDA's Small Entity Compliance Guide (SECG) for the 2023 final rule. The SECG is a plain-language companion document designed to help smaller facilities understand and implement the 2023 amendments. While not itself a regulation, the SECG is an important operational reference — it translates regulatory language into practical implementation guidance and is the document most useful to compliance staff preparing policies and procedures in response to the 2023 update.

View on Federal Register →

---

Reading the Regulatory Record

These four documents do not stand alone. The operative MQSA framework at any given moment is 21 CFR Part 900 as it currently reads — which is the 1997/1999 final rule as amended by all subsequent rulings. When developing policies or preparing for an accreditation inspection, compliance officers should:

1. Start with the current CFR text — available at ecfr.gov — which consolidates all amendments into one readable document.
2. Use the Federal Register documents to understand the intent and history behind specific requirements — particularly useful when a provision is ambiguous or when your accreditation body's interpretation differs from your own reading.
3. Monitor for new publications using the subscription tools described above — the regulatory environment does change, and staying current is itself a compliance obligation.